© 2026 Sinochem Nanjing Corporation,
All Right Reserved
|
HS Code |
275062 |
As an accredited 3-Bromo-5-Fluoro-4-Methoxyaniline factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Bromo-5-Fluoro-4-Methoxyaniline prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
For researchers and process developers, finding the right compound often makes the difference between hitting a dead end and opening a new avenue in drug discovery, material science, or agricultural technology. Few compounds offer the unique touch 3-Bromo-5-Fluoro-4-Methoxyaniline brings to the lab bench. As someone who has spent time chasing elusive yields and troubleshooting synthetic routes, I see chemicals like this not as isolated molecules but as keys that unlock new worlds in chemical synthesis.
3-Bromo-5-Fluoro-4-Methoxyaniline carries the molecular formula C7H7BrFNO, combined with a structure that positions functional groups exactly where they’re needed for downstream modifications. The bromine and fluorine atoms don't just decorate the benzene ring; they set the stage for cross-coupling and functional group transformations. The methoxy brings electron-donating ability, creating a microenvironment ripe for selective reactivity. In my own efforts to push reactivity boundaries in aromatic chemistry, I've leaned on such complexity—knowing just how much substituent position can tip the scales in favor of success.
Looking at its practical form, this compound comes as a pale solid, typically handled in 1-gram bottles all the way up to multi-kilogram lots for pilot work. Purity typically reaches 98% or higher, confirmed by chromatography and spectroscopy. I’ve become cautious through experience: chasing high purity isn't a luxury, it’s a must when micro-impurities ripple downstream, affecting every step in your process.
Anyone who’s tried synthesizing halogenated anilines knows that choice of substituents changes more than just reactivity. In 3-Bromo-5-Fluoro-4-Methoxyaniline, the bromine at position 3 and fluorine at position 5 set up the benzene ring for mild palladium-catalyzed coupling reactions. That’s one reason it appears over and over in medicinal chemistry, even outside big pharma. The methoxy tweaks both the electron density and solubility, letting researchers take routes that stay out of the reach of less nuanced analogs.
From a practical standpoint, such subtle tuning cuts both ways. I can remember times when a single misplaced methoxy or halogen in a custom compound blew up costs and timelines or forced a switch in the synthesis plan. There's a lesson here for anyone moving from bench chemistry to process scale: sacrifice position or protection at your peril.
This isn’t a molecule destined to gather dust on a shelf. 3-Bromo-5-Fluoro-4-Methoxyaniline finds its main calling as an intermediate in the creation of advanced pharmaceuticals and agrochemicals. The combination of halogen and methoxy substituents positions it uniquely for Suzuki-Miyaura and Buchwald-Hartwig reactions, opening doors to subtler kinds of substitutions. I’ve watched these reactions cut weeks—sometimes months—from development timelines by letting chemists graft complex fragments onto the core with just a tweak of catalyst or base.
In pharmaceutical settings, the road from intermediate to finished active compound can hinge on the ease of introducing functionality at specific ring positions. Medicinal chemists look for ways to tune solubility, binding affinity, and metabolic stability. Here, a well-placed methoxy or halogen acts like a Swiss Army knife, rolling several synthetic options into one molecule. This flexibility can mean real, tangible progress on tough structure–activity relationships or stubborn metabolism roadblocks.
On the agricultural side, effort often focuses on building selective herbicides or fungicides that require little post-processing. I recall projects where tight control over substitution patterns yielded better environmental fate—biodegradation rates, soil mobility—making regulatory approval more realistic. Building blocks like 3-Bromo-5-Fluoro-4-Methoxyaniline save time, both in synthesis and in the regulatory grind.
I've worked with a variety of haloanilines, and the differences show up fast as you move into late-stage synthesis steps. Standard bromoanilines offer decent reactivity in cross-coupling, but without a useful electron-donating group, their selectivity drops, and yields suffer. Fluoroanilines handle nucleophilic aromatic substitution better, but lack flexibility in transition metal catalysis. Methoxyanilines help introduce O- or N-functionalities but don’t combine well with halogens for stepwise modifications.
3-Bromo-5-Fluoro-4-Methoxyaniline’s trifecta—bromine, fluorine, methoxy—brings a rare balance. The methoxy at position 4 directs reactivity, boosting regioselectivity and making purification less of a headache. Back in graduate school, I learned firsthand how the wrong substitution pattern led to by-products that were nearly impossible to separate. Tweaked structures like this save real money and sanity, not just footnotes in a synthetic scheme.
Another point worth emphasizing: downstream functionalization opens up many more possibilities. With just a single molecule, you can take the synthesis in several directions, each with potential for patentable new entities or process improvements. Standard anilines become bottlenecks; this compound gives options, something in short supply during route scouting.
We all know a reagent only delivers what’s promised if starting purity lines up. The pathway from intermediate to active pharmaceutical ingredient (API) runs right through impurities. Years ago, we traced a yield anomaly to a single percentage point loss of purity in the starting haloaniline. This kind of setback drives home why reputable sources and full traceability matter so much.
Reports from experienced chemists reinforce the same lesson: material that falls even a point short on purity leads to side products, catalyst failure, or regulatory headaches. A good batch of 3-Bromo-5-Fluoro-4-Methoxyaniline should make it through strict NMR and HPLC analysis, come packed to minimize moisture pickup, and be ready for scale-up—without unexpected shop-floor disasters. I trust suppliers who share their batch analysis, making it possible to trace every critical spec from end to end.
Halogenated anilines rarely match the ease of handling seen with more common building blocks. In everyday lab practice, exposure to air and moisture can lead to hydrolysis or oxidation, particularly if immediate downstream use isn’t planned. I’ve learned to keep such intermediates tightly sealed, stored in amber bottles, and away from sunlight. There’s no room for sloppiness when a compromised batch could cost a week’s worth of scale-up work.
From a safety perspective, standard protocols for anilines apply: gloves, fume hood, and clear labeling. Brominated and fluorinated aromatic amines sometimes carry slightly higher risk profiles for operator exposure, both inhalation and dermal. While most accidents stem from poor technique rather than any intrinsic danger, extra vigilance with these isn’t wasted effort. Years of safe practice in my lab boiled down to consistency on the basics and a dose of humility—always double-check the MSDS and updated literature.
Global disruptions over the past decade have laid bare just how fragile chemical supply lines can be. Raw material shortages, regulatory changes, or an uptick in demand sometimes cause long lead times or sudden price jumps in specialty compounds. Real professionals don’t put all their bets on a single supplier or overlook the role of backup stocks.
Some manufacturers now keep versatile intermediates like 3-Bromo-5-Fluoro-4-Methoxyaniline in inventory for fast turnaround, easing the pain of fluctuations in demand. Personally, I recommend building relationships with trusted sources long before a shortage hits. Don’t get stuck placing last-minute emergency orders—they add stress, risk, and cost. Connect early, share project timelines, and insist on batch consistency to save yourself trouble as scale increases.
Chemists face a balancing act: bring new molecules to market, but cut waste, energy use, and toxic byproducts. Here, a compound that supports selective, catalyst-driven transformations helps meet sustainability goals. Using a building block that allows for more efficient reaction pathways often means fewer steps, less solvent, and less post-processing waste.
Environmental regulations keep tightening, especially on large-scale campaigns. The days of ignoring atom economy and environmental impact are over. In my own experience, being able to cut out even one workup or wasteful reaction can shave costs, impress regulators, and give your project a clearer path forward. Selecting a starting material like this often helps compliance, not just science.
Novel compounds and intermediates often carry intellectual property (IP) advantages. Modifying known drugs or agrochemicals with strategic substituents can open new patent filings or extend exclusivity periods, and 3-Bromo-5-Fluoro-4-Methoxyaniline’s structure matches these needs. Medicinal chemists know that even minor changes in the aromatic region can unlock a wealth of new patent claims.
For startups and process innovators, controlling access to rare intermediates can tip negotiations with partners or investors. I’ve seen projects move from academic curiosity to commercial viability based on the ability to patent a series of analogs stemming from such a building block. The strategic value goes beyond what’s on a spec sheet or catalog listing.
I’ve watched synthetic teams move from legacy bromoanilines to this more highly functionalized type and seen improved tolerance to mild aqueous conditions, higher cross-coupling yields, and lower off-target reactivity. Sometimes, moving from trial to pilot scale reveals hidden differences—robustness, cost-per-batch, or ease of purification. Using the right intermediate streamlines everything from discovery to kilo lab.
One telling feature: by integrating fluorine, later-stage molecules inherit better chemical and metabolic stability. In drug development, this often translates into greater bioavailability or a better safety profile. High-performance mats benefit from similar mechanics, where the tailored combination of halogen and O-alkyl groups modifies surface energies or mechanical characteristics. Even if you’re not synthesizing the next blockbuster drug, the benefits echo through downstream applications.
Choosing the right starting materials can be as much art as science. In my own trials with complex aromatic syntheses, single impurities or misplaced functional groups sometimes derailed months of work. For those starting fresh, thin-layer chromatography makes a fast check for purity; NMR and mass spectrometry will confirm integrity if questions arise.
Lab practices tend to drift without reminders, especially if team members rotate in and out. I suggest keeping a written log for any new lot, including notes on melting point, storage behavior, and first-use observations. These become invaluable if trouble arises or another team comes on board later. A compound like 3-Bromo-5-Fluoro-4-Methoxyaniline, with its multiple reactive sites, deserves close attention on each run.
A few suggestions stand out from my years in specialty chemistry. Work with suppliers who provide transparent quality documentation up front—ideally, those who back it up with recent analytical data. For critical work, insist on a signed certificate with each batch, not just a verbal assurance or recycled analysis. If possible, perform your own verification as well.
On the inventory side, buffer stock remains your best insurance against unpredictable supply chain hiccups. Track expiration and requalification dates, particularly for larger orders, and stagger inventory if usage fluctuates. Build redundancy into your synthetic plans. In one case, I worked alongside a team who alternated between different sources and chemical lots to de-risk late-stage campaigns.
No amount of technical prowess substitutes for strong communication among chemists, analysts, and procurement staff. Teams who build a habit of passing on key handling, storage, and analytical notes bypass a lot of avoidable setbacks. Experience shows that sharing these details—rather than treating intermediates as routine—shortens timelines, keeps budgets realistic, and avoids regulatory missteps.
The biggest problems I’ve watched unfold involved poor communication or skipped documentation on reactivity, impurity profiles, or shelf life. Prompt, honest reporting and record-keeping keep teams aligned and resilient, especially as projects shift hands or move overseas.
Every year, the demands on chemical innovation get steeper. Time-to-market shrinks, regulatory hoops multiply, and budgets rarely get friendlier. Against this backdrop, having access to a finely tuned intermediate gives a critical edge. I’ve seen process teams ride such advantages from hit compound to full-scale launch—outpacing less adaptable operations weighed down by rigid synthetic sequences.
At the end of the day, compounds like 3-Bromo-5-Fluoro-4-Methoxyaniline do not just fill gaps in a synthetic lineup. They provide flexibility, reliability, and a foundation for the next leap forward in discovery, scale-up, and commercial application. For those of us who have lived the ups and downs of chemical manufacturing and R&D, the choice of building block remains as much about shaping outcomes as following protocols. This is the difference that can decide tomorrow’s breakthroughs.
